Decisions Home

United Kingdom Self-Monitoring Blood Glucose Market Insight

Published: 18 June 2026   |   Report Format: Electronic (PDF)

The United Kingdom Self-Monitoring Blood Glucose Market is projected to grow at a CAGR of around 6.3%, driven by the rising prevalence of diabetes and growing adoption of home-based monitoring devices.

United Kingdom Self-Monitoring Blood Glucose Market Forecasts to 2035

  • The United Kingdom Self-Monitoring Blood Glucose Market size was estimated at approximately USD 620 Million in 2025.
  • The market is expected to grow at a CAGR of around 6.3% from 2025 to 2035.
  • The United Kingdom Self-Monitoring Blood Glucose Market is projected to reach approximately USD 1,150 Million by 2035.

Notable Insights for the United Kingdom Self-Monitoring Blood Glucose Market

  • Segmentation based on product type indicates Blood Glucose Meters account for approximately 41% market share in 2025, driven by widespread utilization among diabetic patients for routine glucose monitoring.
  • Segmentation based on end-user shows Home Care Settings holding nearly 56% market share in 2025, supported by increasing preference for self-monitoring and remote diabetes management.
  • The market is led by major companies including Abbott Laboratories, F. Hoffmann-La Roche Ltd., Ascensia Diabetes Care Holdings AG, LifeScan Inc., and Medtronic plc, collectively accounting for approximately 52% market share in 2025.
  • Rising diabetes prevalence and increased adoption of digital glucose monitoring technologies have contributed to approximately 33% growth in self-monitoring device usage over the past five years.

Download the eBook (ToC)

We value your privacy.

Research Methodologies Used to Analyze United Kingdom Self-Monitoring Blood Glucose Market

The United Kingdom Self-Monitoring Blood Glucose Market is analyzed using a combination of primary and secondary research methodologies to ensure accurate market estimation, competitive benchmarking, and forecasting. Primary research includes interviews with endocrinologists, diabetologists, primary care physicians, diabetes educators, healthcare providers, distributors, and industry experts. Secondary research involves company annual reports, healthcare publications, government healthcare statistics, regulatory databases, scientific journals, and market intelligence sources. Data triangulation, demand-supply analysis, and statistical forecasting models are applied to validate market insights and provide reliable forecasts through 2035.

 

Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making

What is Decisions Advisors Research?

Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom Self-Monitoring Blood Glucose Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

Top Companies in United Kingdom Self-Monitoring Blood Glucose Market

 

Recent Developments:

 

Market Segmentation:

United Kingdom Self-Monitoring Blood Glucose Market, By Product Type

United Kingdom Self-Monitoring Blood Glucose Market, By Distribution Channel

United Kingdom Self-Monitoring Blood Glucose Market, By End User

 

Expert Views:

The United Kingdom Self-Monitoring Blood Glucose Market is expected to witness robust growth through 2035, supported by increasing diabetes incidence, growing emphasis on preventive healthcare, and rising adoption of digital health technologies. Advancements in connected glucose monitoring devices, smartphone-integrated diabetes management platforms, cloud-based health tracking systems, and patient-centric monitoring solutions are anticipated to improve disease management and strengthen long-term market growth across the healthcare sector.


Author: Govind and Krishna By Decisions Advisors and Consulting